PRODUCT

Duque de Caxias - Rio de Janeiro

​

FLUESOCIL®

fludesoxyglucose (18 F)
 

Presentation: Shielded packaging containing 01 multidose vial

Pharmaceutical Form: Sterile Solution

Route of administration: Intravenous

Composition: Each radiopharmaceutical vial contains:

Fludesoxyglucose (18 F) …………… 10mCi

Excipients: 0.9% sodium chloride and water for injection.

Physical half-life: 109.7 minutes

Indications: Positron Emission Tomography (PET and PET-CT) imaging diagnosis for oncological, brain and cardiac studies.